• LAST PRICE
    31.7100
  • TODAY'S CHANGE (%)
    Trending Up0.8800 (2.8544%)
  • Bid / Lots
    30.2300/ 1
  • Ask / Lots
    33.4800/ 6
  • Open / Previous Close
    30.9600 / 30.8300
  • Day Range
    Low 30.9600
    High 32.1800
  • 52 Week Range
    Low 29.7200
    High 76.9800
  • Volume
    298,637
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 30.83
TimeVolumeIMCR
08:32 ET33830.96
08:34 ET20031.735
08:38 ET10031.33
08:43 ET263931.5
08:48 ET20031.345
08:52 ET10031.36
08:54 ET137531.495
08:56 ET20031.37
08:57 ET10031.49
09:06 ET40031.485
09:08 ET50031.47
09:10 ET20031.46
09:12 ET20031.54
09:15 ET62931.65
09:17 ET92931.7
09:19 ET45331.69
09:21 ET60031.94
09:24 ET140031.78
09:26 ET695632
09:28 ET30031.97
09:30 ET50632.045
09:32 ET20032.045
09:33 ET347031.87
09:37 ET10031.835
09:39 ET56031.85
09:42 ET396031.86
09:44 ET90031.89
09:46 ET30031.83
09:48 ET90031.84
09:50 ET190031.87
09:51 ET222031.88
09:53 ET433431.83
09:55 ET50031.68
09:57 ET70031.745
10:00 ET40031.75
10:02 ET100031.75
10:04 ET40031.74
10:06 ET60031.79
10:09 ET516131.29
10:11 ET86331.14
10:15 ET40031.17
10:20 ET30031.255
10:24 ET10031.33
10:26 ET30031.26
10:27 ET20031.16
10:29 ET176031.08
10:33 ET264731.255
10:36 ET40031.325
10:38 ET140231.29
10:40 ET10031.335
10:42 ET50231.38
10:44 ET20031.4
10:45 ET10031.445
10:47 ET10031.44
10:49 ET10031.445
10:51 ET90031.36
10:56 ET30031.39
10:58 ET75931.35
11:00 ET10031.34
11:02 ET50031.455
11:05 ET10031.46
11:12 ET83031.46
11:14 ET60031.52
11:16 ET122031.58
11:18 ET24831.65
11:20 ET94031.63
11:21 ET42031.68
11:23 ET30031.68
11:25 ET60431.67
11:27 ET60031.67
11:30 ET80031.76
11:32 ET188831.68
11:38 ET44331.74
11:39 ET60031.73
11:41 ET10031.77
11:43 ET40031.71
11:45 ET321231.65
11:48 ET85031.715
11:50 ET10031.71
11:52 ET120031.695
11:54 ET106531.69
11:56 ET50031.69
11:57 ET40031.74
11:59 ET70031.75
12:01 ET60031.75
12:06 ET22031.83
12:08 ET10031.77
12:10 ET30031.67
12:12 ET10031.67
12:14 ET99131.78
12:15 ET72031.745
12:17 ET20031.8
12:19 ET132331.785
12:21 ET22031.81
12:24 ET10031.88
12:28 ET70031.92
12:30 ET20031.92
12:33 ET140031.81
12:37 ET10031.79
12:46 ET30031.67
12:48 ET10031.67
12:51 ET20031.61
12:53 ET118331.675
12:55 ET10031.75
12:57 ET53331.59
01:02 ET10031.61
01:04 ET10031.635
01:06 ET122731.47
01:09 ET78931.41
01:13 ET10031.37
01:24 ET413031.455
01:27 ET30031.58
01:29 ET10031.68
01:31 ET11631.605
01:33 ET40031.66
01:38 ET22331.64
01:40 ET10031.625
01:44 ET97731.71
01:45 ET10031.77
01:49 ET10031.94
01:51 ET40031.855
01:54 ET30031.87
01:56 ET20031.88
02:00 ET70031.935
02:02 ET40031.91
02:03 ET10031.87
02:05 ET430731.77
02:09 ET168631.82
02:12 ET310531.79
02:14 ET72031.81
02:16 ET231631.78
02:18 ET80031.73
02:20 ET135831.73
02:21 ET138031.765
02:23 ET302231.78
02:25 ET273031.8
02:27 ET172831.84
02:30 ET685931.83
02:32 ET60031.825
02:34 ET451831.795
02:36 ET255031.71
02:38 ET10031.715
02:39 ET20031.725
02:41 ET396231.55
02:43 ET99931.52
02:45 ET250331.54
02:48 ET290031.445
02:50 ET60031.445
02:52 ET178731.455
02:54 ET266731.485
02:56 ET212031.49
02:57 ET1535931.58
02:59 ET4895431.7
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMCR
Immunocore Holdings PLC
1.6B
-29.6x
---
United StatesHROW
Harrow Inc
1.6B
-48.0x
---
United StatesINVA
Innoviva Inc
1.2B
11.7x
-8.76%
United StatesEOLS
Evolus Inc
1.1B
-18.4x
---
United StatesLGND
Ligand Pharmaceuticals Inc
2.0B
49.5x
-12.71%
United StatesOCUL
Ocular Therapeutix Inc
1.6B
-9.5x
---
As of 2024-11-04

Company Information

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters
90 Park Drive, Milton Park, AbABINGDON, United Kingdom OX14 4RY
Phone
123-543-8600
Fax
---

Executives

Independent Chairman of the Board
John Bell
Chief Executive Officer, Director
Bahija Jallal
Chief Financial Officer, Head of Strategy
Brian Di Donato
Chief Human Resource Officer
Tina St Leger
Head of Research and Development
David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6B
Revenue (TTM)
$281.5M
Shares Outstanding
50.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.72
EPS
$-1.07
Book Value
$7.42
P/E Ratio
-29.6x
Price/Sales (TTM)
5.6
Price/Cash Flow (TTM)
---
Operating Margin
-21.78%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.